drugset / Trial / NCT01472497

Effects of Pioglitazone in Hypertensive Patients

NCT01472497

Phase 4 Completed 16 enrolled Tottori University Hospital
NaSingle-groupDouble-blindTreatment

Summary

Insulin resistance is often complicated with hypertension. AGE and inflammation play important roles in insulin resistance. Some studies reported that pioglitazone, insulin sensitizer, is effective for patients with insulin resistance, however, the mechanisms are still unclear. The aim of this study to evaluate the effect of pioglitazone compared with glimepiride on AGE, inflammatory cytokines and cardiac markers (BNP and echo) in hypertensive patients during oral glucose tolerance test.

Timeline

Start
2007-04
Primary completion
2011-12
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule 15 mg

Indications